Article
Successful Haploidentical Bone Marrow Transplantation of an Infant With a Novel Mutation in SAMD9L Gene (Ataxia-Pancytopenia Syndrome).
Journal of pediatric hematology/oncology - 1 Oct 2022
Alicea Marrero Minelys M, Español María, Marrero-Rivera Gisela, Bauchat Andrea, Cruz Valerie, Yu Lolie, LeBlanc Zachary
Abstract excerpt
Data regarding the outcomes of hematopoietic stem cell transplant (HSCT) for the management of SAMD9L -associated ataxia-pancytopenia syndrome remains limited. We depict the case of a 2-month-old male with a novel mutation in the SAMD9L gene, presenting with respiratory failure, pancytopenia and severe developmental delay. He experienced graft failure 2 months after a 4/6 HLA-matched cord HSCT. At 9 months old,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
